AInvest Newsletter
Daily stocks & crypto headlines, free to your inbox
Top Analysts Pick: 3 Stocks to Buy Now for Significant Upside
ByAinvest
Thursday, Jul 24, 2025 6:01 am ET1min read
Three stocks to buy now, according to top analysts, include Crinetics Pharmaceuticals (CRNX) with a 159.5% upside, Backblaze (BLZE) with a 102.95% upside, and DraftKings (DKNG) with a 22.37% upside. The stocks received new Buy ratings recently and have significant potential for growth. TipRanks' Analyst Top Stocks tool can help investors find more stocks like these.
Top analysts have recently issued new Buy ratings for three stocks, each with significant upside potential. Crinetics Pharmaceuticals (CRNX) stands out with a 159.5% upside, followed by Backblaze (BLZE) at 102.95%, and DraftKings (DKNG) with a 22.37% upside.Crinetics Pharmaceuticals (CRNX)
H.C. Wainwright has reiterated its Buy rating and $81.00 price target on Crinetics Pharmaceuticals (CRNX), representing a substantial 159.5% upside from the current price of $31.11 [1]. The research firm highlighted strong enthusiasm from expert endocrinologists toward Crinetics' lead drug candidate, paltusotine. The drug has demonstrated consistent biochemical and symptom control in acromegaly patients, with a once-daily dosing regimen as a key advantage.
Backblaze (BLZE)
Backblaze (BLZE) has also received a new Buy rating, with a 102.95% upside potential. The company recently announced its second quarter 2025 financial results will be released on August 7, 2025 [2]. Backblaze has been recognized for its cost-effective cloud storage solutions, with an independent report by Enterprise Strategy Group (ESG) demonstrating up to 3.2x lower total cost of ownership (TCO) compared to traditional providers [2].
DraftKings (DKNG)
DraftKings (DKNG) received a new Buy rating with a 22.37% upside. The stock has been gaining attention for its growth potential in the sports betting and daily fantasy sports (DFS) sectors. The company continues to expand its offerings and partnerships, contributing to its positive outlook.
Investors seeking more opportunities like these can use the TipRanks' Analyst Top Stocks tool to find additional stocks with strong analyst support.
References:
[1] https://www.investing.com/news/analyst-ratings/hc-wainwright-reiterates-buy-rating-on-crinetics-stock-at-81-price-target-93CH-4143703
[2] https://www.stocktitan.net/news/BLZE/
Ainvest News articles are AI-generated using advanced large language model (LLM) technology designed to analyze and synthesize publicly available data and news. While AI tools assist in producing initial drafts and insights, all AI generated content published on Ainvest is subject to comprehensive human editorial review before publication. A designated human editor reviews, verifies, and approves each article for factual accuracy, coherence, and compliance with AInvest Fintech Inc’s editorial and disclosure standards.
Despite these review procedures, the information provided may still contain inaccuracies, incomplete data, or time sensitive references due to the inherent limitations of AI generated analysis and evolving changes. The material is provided strictly for informational and educational purposes and does not constitute personalized investment, legal, or financial advice. Readers should independently verify all facts, figures, and statements before making any decision based on this content.
AInvest Fintech Inc. its affiliates, and partners accept no liability or responsibility for any direct or consequential losses arising from reliance on this content. All articles and analyses are subject to revision, update, or removal without prior notice to maintain accuracy and integrity in our publications.
Comments
No comments yet